FDA : Six people died during Pfizer vaccine trial
9th December the U.S. Food and Drug Administration (FDA) is also actively promoting the approval and authorization of the vaccine after the United Kingdom began to vaccinate people against Pfizer against the novel coronavirus.
However, a meeting document of the U.S. Food and Drug Administration shows that a total of six people died in Pfizer’s late trials of the vaccine, and its Two of them died after being vaccinated.
Two patients who died after the vaccine were reported to be older than 55 years old.
One of them had already suffered from arteriosclerosis, and the other had cardiac arrest 60 days after the second dose of the vaccine.
FDA experts will meet on Thursday to approve Pfizer vaccines.
Officials issued documents prior to the meeting noting that the Pfizer vaccine data submitted met the relevant guidelines for emergency use authorization.
